Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mecasermin in Friedreich's Ataxia
2011-004104-38Phase 3Active
- Sponsor
- FIBHULP
- Start
- Jan 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of mecasermin in Friedreich ataxia (FA), sponsored by FIBHULP. Started Jan 2012; status: active.
02
Drugs
mecasermin
03
Conditions
Friedreich ataxia (FA)
Beyond the preview
Go deeper on 2011-004104-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004104-38.